Literature DB >> 10641791

The transcription factor Evi-1.

H Hirai1.   

Abstract

Evi-1 is a transcription factor with two sets of zinc finger domains. The temporally and spatially restricted pattern of Evi-1 expression in embryonic tissues suggests a role of Evi-1 in organogenesis and morphogenesis in mouse development. Mice lacking Evi-1, which die within the first few weeks of life with multiple defects in embryonic development, suggest that Evi-1 is essential for developmental cell proliferation, vascularization, and cell-specific signaling at midgestation. In hematopoietic cells, Evi-1 expression is restricted at a transient stage of myeloid cell differentiation. Constitutive expression of Evi-1 in hematopoietic cells, which is caused by retroviral insertions or chromosomal translocations and inversions, is closely associated with myelogenous leukemias and myelodysplastic syndromes in mice and humans. In the aspect of potential therapeutic approaches, some pharmaceutical drugs or antisense oligonucleotides that repress Evi-1 expression would be useful for the treatment of Evi-1-induced neoplastic tumors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10641791     DOI: 10.1016/s1357-2725(99)00064-3

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  7 in total

1.  Evi1 regulates Notch activation to induce zebrafish hematopoietic stem cell emergence.

Authors:  Martina Konantz; Elisa Alghisi; Joëlle S Müller; Anna Lenard; Virginie Esain; Kelli J Carroll; Lothar Kanz; Trista E North; Claudia Lengerke
Journal:  EMBO J       Date:  2016-09-16       Impact factor: 11.598

Review 2.  Runx1/AML1 in normal and abnormal hematopoiesis.

Authors:  Tetsuya Yamagata; Kazuhiro Maki; Kinuko Mitani
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

3.  EVI1 splice variants modulate functional responses in ovarian cancer cells.

Authors:  Punashi Dutta; Tuyen Bui; Kyle A Bauckman; Khandan Keyomarsi; Gordon B Mills; Meera Nanjundan
Journal:  Mol Oncol       Date:  2013-03-05       Impact factor: 6.603

4.  Mutation at the Evi1 locus in Junbo mice causes susceptibility to otitis media.

Authors:  Nicholas Parkinson; Rachel E Hardisty-Hughes; Hilda Tateossian; Hsun-Tien Tsai; Debra Brooker; Sue Morse; Zuzanna Lalane; Francesca MacKenzie; Martin Fray; Pete Glenister; Anne-Marie Woodward; Sian Polley; Ivana Barbaric; Neil Dear; Tertius A Hough; A Jackie Hunter; Michael T Cheeseman; Steve D M Brown
Journal:  PLoS Genet       Date:  2006-10-06       Impact factor: 5.917

5.  Integrative genomic analysis of peritoneal malignant mesothelioma: understanding a case with extraordinary chemotherapy response.

Authors:  Christin Lund-Andersen; Sigve Nakken; Ståle Nygård; Bastian Fromm; Lars B Aasheim; Ben Davidson; Lars Julsrud; Torveig W Abrahamsen; Annette T Kristensen; Brit Dybdahl; Stein G Larsen; Eivind Hovig; Kjersti Flatmark
Journal:  Cold Spring Harb Mol Case Stud       Date:  2019-04-01

6.  PRDM Proteins: Molecular Mechanisms in Signal Transduction and Transcriptional Regulation.

Authors:  Erika Di Zazzo; Caterina De Rosa; Ciro Abbondanza; Bruno Moncharmont
Journal:  Biology (Basel)       Date:  2013-01-14

7.  Differential epigenetic regulation between the alternative promoters, PRDM1α and PRDM1β, of the tumour suppressor gene PRDM1 in human multiple myeloma cells.

Authors:  Raquel Romero-García; Laura Gómez-Jaramillo; Rosa María Mateos; Gema Jiménez-Gómez; Nuria Pedreño-Horrillo; Esther Foncubierta; Juan Francisco Rodríguez-Gutiérrez; Sebastián Garzón; Francisco Mora-López; Carmen Rodríguez; Luis M Valor; Antonio Campos-Caro
Journal:  Sci Rep       Date:  2020-09-28       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.